Exagen financial statements

엑사젠NASDAQ:XGN · Nasdaq · Healthcare · sector #17
$8.19-3.19%
2026-10-06 close

Exagen's published financial data is dated 2026-10-04. 2024 revenue was $56M. 2024 operating profit was −$14M.

Reported results

Exagen notifications

Quantus Signal · live data · not investment advice · Privacy Policy